Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00029
|
|||||
| Drug Name |
Moxidectin
|
|||||
| Synonyms |
C37H53NO8; Cydectin; Moxidectin [USAN:INN:BAN]; Moxidectina; Moxidectina [INN-Spanish]; Moxidectine; Moxidectine [INN-French]; Moxidectinum; Moxidectinum [INN-Latin]; NGU5H31YO9; ProHeart 6; UNII-NGU5H31YO9
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Onchocerciasis [ICD11: 1F6A] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C37H53NO8
|
|||||
| Canonical SMILES |
CC1CC(=CCC2CC(CC3(O2)CC(=NOC)C(C(O3)C(=CC(C)C)C)C)OC(=O)C4C=C(C(C5C4(C(=CC=C1)CO5)O)O)C)C
|
|||||
| InChI |
InChI=1S/C37H53NO8/c1-21(2)14-25(6)33-26(7)31(38-42-8)19-36(46-33)18-29-17-28(45-36)13-12-23(4)15-22(3)10-9-11-27-20-43-34-32(39)24(5)16-30(35(40)44-29)37(27,34)41/h9-12,14,16,21-22,26,28-30,32-34,39,41H,13,15,17-20H2,1-8H3/b10-9+,23-12+,25-14+,27-11+,38-31+/t22-,26-,28+,29-,30-,32+,33+,34+,36-,37+/m0/s1
|
|||||
| InChIKey |
YZBLFMPOMVTDJY-LSGXYNIPSA-N
|
|||||
| CAS Number |
CAS 113507-06-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 639.8 | Topological Polar Surface Area | 116 | ||
| Heavy Atom Count | 46 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 9 | |||
| XLogP |
4.3
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | ||
| References | ||||||
| 1 | Moxidectin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Moxidectin and the avermectins: Consanguinity but not identity. Int J Parasitol Drugs Drug Resist. 2012 Apr 14;2:134-53. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.